Xingjuan Chao

CBLL CEO Xingjuan Chao sells 39,000 shares for $714,870.00 via scheduled 10b5-1 plan

Xingjuan Chao, President and CEO of Ceribell, Inc., executed 3 separate sales totaling 39,000 shares for $714,870.00 on 2026-06-08 at $18.33 per share under a pre-arranged 10b5-1 trading plan, reducing non-derivative holdings to 816,317 shares. The transaction is scheduled rather than discretionary, removing timing as an interpretive variable. The company reported a net loss of $19,737,000.00 on revenue of $26,494,000.00 in its latest quarter and remains unprofitable on a full-year basis, despite annual revenue growth of +36.1%. The current stock price of $18.63 sits 23.4% below its 52-week high of $24.33 and down 7.1% over 30 days. The CEO retains 391,633 shares in derivative holdings (stock options), preserving meaningful economic exposure.

Ceribell CEO sells ~$783k in shares as stock trades well below recent highs; unprofitable company with strong revenue growth.

Chao Xingjuan, Ceribell's President and CEO, sold approximately $783,973 in shares on a single date through five separate transactions, representing about 4.5% of his holdings. The stock is currently trading well below its recent highs and has remained flat over the past quarter, creating an unfavorable backdrop for equity sales. Notably, Chao's prior sales in this same stock have shown consistently poor timing — the stock rose modestly to meaningfully after each of his previous exits, meaning he has missed gains on every prior occasion. Adding to the headwind, Ceribell remains unprofitable on a net income basis despite strong revenue growth, which suggests the company is in a capital-intensive or competitive phase where operational results remain deeply negative. This sale from the CEO lacks the conviction signal one might expect from a company insider and instead reads as straightforward portfolio activity in a struggling stock.

CEO Chao Xingjuan sells 39,000 shares (4.4% of holdings) at $18.40 in 3 tranches; stock down 20.3% from 52-week high.

Chao Xingjuan, President and CEO of Ceribell, Inc., executed 3 separate sales totaling 39,000 shares for $717,600.00 at $18.40 on 2026-04-06, reducing his stake from 889,347 shares to 850,347 shares. The timing aligns with material headwinds: the company is unprofitable (net income $-13,465,000.00 for the most recent full fiscal year), the stock is trading 20.3% below its 52-week high, and the 90-day return is -19.0%. Within Chao's same-ticker history at CBLL, his most recent sales on 2026-03-03 showed a 30-day return of +6.4%, but prior measurable outcomes at this ticker have not validated well-timed execution. The cross-ticker track record shows a 75.00% well-timed rate on sells historically, but that does not necessarily predict timing accuracy for this specific CBLL transaction given the stock's recent deterioration and the company's ongoing profitability challenges.

CEO Chao Xingjuan sells 39,000 shares at $17.45 blended average; stock down -12.6% in 30 days, company unprofitable.

Chao Xingjuan, President and CEO of Ceribell, executed 3 separate sales totaling 39,000 shares for $680,564.46 at a blended average price of $17.45. This represents a 5.2% reduction in his holdings to 711,164 shares post-transaction. The timing context is notable: the stock has declined 12.6% over the prior 30 days and sits 27.3% below its 52-week high of $24.62. At the same ticker, Chao has executed 5 prior sales in recent weeks (three on 2026-02-04 and two on 2026-01-05), with the January sales showing 30-day negative returns of -4.8% and -5.4%. Structurally, the company is unprofitable with net income of $-13,465,000.00 against revenue of $22,589,000.00, though revenue is growing at 36.1% annually. The pattern of repeated CEO selling into a declining stock price, combined with the company's current unprofitability, merits investor attention.

CEO Chao Xingjuan sold 39,000 shares at $20.16 for $786,240 on 2026-02-04; stock down 21.1% from 52-week high

Chao Xingjuan, the President and CEO, executed 3 separate sales totaling 39,000 shares (39.0K shares) for $786,240.00 ($786.2K), reducing his holdings from 766,248 shares (766.2K shares) to 727,248 shares (727.2K shares). The sales occurred at $20.16, which is 0.05 below the current price of $20.15, and represent a sale point -21.1% below the 52-week high of $25.54. Ceribell remains unprofitable on a full-year basis with a net income of $-13,465,000.00 ($-13.5M) in the latest quarter against revenue of $22,589,000.00 ($22.6M), though annual revenue growth stands at +44.7%. His prior three sales at CBLL on 2026-01-05 each showed negative 30-day returns (-5.4%, -5.0%, -4.8%), while the stock is currently -11.7% over 30 days from the transaction date. The timing pattern across his same-ticker history shows no measurable well-timed outcomes at the 90-day horizon.

CBLL CEO Chao Xingjuan sells 79,000 shares ($1.7M) at $21.27 blended avg; retains 741.2K shares post-trade

Chao Xingjuan, President and CEO of Ceribell Inc., executed 3 separate sales totaling 79,000 shares for $1,680,047.84 at a blended average price of $21.27 on 2026-01-05. The disposition reduced his holdings by 9.6% to 741,248 shares remaining. Against the current price of $22.83, the insider sold at a 5.8% discount to today's market, and the stock has rallied 12.9% over 30 days and 78.1% over 90 days—a strong price trajectory that occurred after the sale. Ceribell remains unprofitable with net income of $-13,465,000.00 against $22,589,000.00 in quarterly revenue, despite 44.7% annual revenue growth; the $846.9M market cap reflects a high-growth but loss-making profile. The insider's cross-ticker track record shows 1 prior sell with a +40.1% 30-day return, and his prior CBLL trade (a sell on 2025-11-21) also returned +40.1% at 30 days, suggesting a pattern of selling ahead of near-term strength rather than into weakness.

CEO Chao Xingjuan sold 50,000 shares at $15.13; stock now at $17.35, up 34.6% in 30 days amid unprofitability.

Chao Xingjuan, President and CEO, sold 50,000 shares (5.9% of pre-transaction holdings) at $15.13 on 2025-11-21, reducing holdings to 798,135 shares. The sale occurred below the current market price of $17.35 and well below the 52-week high of $30.24. Most notably, the stock has appreciated 34.6% over the prior 30 days and 49.6% over 90 days, suggesting the company's trajectory has recently improved. However, this momentum contrasts sharply with fundamental weakness: the company posted a net loss of $-13,465,000.00 last quarter on revenue of $22,589,000.00 and was unprofitable over the full fiscal year, despite annual revenue growth of 44.7%. The timing of this sale—during a period of strong recent share price recovery but amid ongoing losses—warrants investor scrutiny regarding management's assessment of the company's near-term outlook.